Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dihydrodesoxycodeine-D is a semi-synthetic opioid compound, historically described as a chemical intermediate or derivative related to codeine. It is produced through the catalytic reduction of α-chlorocodide, itself derived from codeine, and serves as a precursor in the synthesis of other opioids, such as dihydrodesoxymorphine-D (desomorphine)[4][6]. Dihydrodesoxycodeine-D is not used clinically as an approved medication, but is relevant in the context of opioid chemistry and synthesis. Its mechanism of action would theoretically involve agonism at the mu-opioid receptor, as with other opioids, leading to analgesic and sedative effects; however, no direct clinical use or pharmacological data are reported for the compound itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dihydrodesoxycodeine-D.